Original Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2013; 19(14): 2154-2161
Published online Apr 14, 2013. doi: 10.3748/wjg.v19.i14.2154
Table 1 Demographic data of the 796 patients with gastric cancer n (%)
Age (yr)Median58 (22-90)
SexMale552 (69)
Female244 (31)
Median follow-up time12 mo (range: 1-276 mo)
Median survival12 mo (range: 11.5-12.4 mo)
Tumor locationPyloric + antrum362 (45.4)
Large and small curvature252 (31.6)
Cardio-esophageal97 (12.2)
Diffuse9 (1.1)
StageStage I29 (3.6)
Stage II43 (5.4)
Stage III195 (24.5)
Stage IV393 (49.3)
Type of surgeryTotal gastrectomy265 (33.2)
Subtotal gastrectomy174 (21.8)
Inoperable/palliative341 (42.8)
TreatmentAdjuvant352 (44.2)
Metastatic394 (49.4)
Untreated follow-up50 (3.9)
HistologyAdenocarcinoma (intestinal type)493 (61.9)
Signet ring cell (diffuse)254 (31.9)
Neuroendocrine24 (3)
Others8 (1.1)
In metastasisPeritonitis carcinomatosa193 (24.2)
Liver169 (21.2)
Lymphadenopathy73 (9.2)
Liver + peritoneum35 (4.4)
Lung28 (3.5)
Pleural effusion + acid24 (3)
Bone23 (2.9)
Others17 (2.1)
Recurrence inPeritonitis carcinomatosa61 (40.1)
Liver36 (23.7)
Lymphadenopathy24 (15.8)
Local14 (9.2)
Pleural/lung12 (7.9)
Others5 (5)